Stockscreener 앱 받기
0.7775
2.81%
-0.0225
전일 마감가:
$0.80
열려 있는:
$0.786
하루 거래량:
81,530
Relative Volume:
0.79
시가총액:
$5.33M
수익:
$1.78M
순이익/손실:
$-13.98M
주가수익비율:
-0.1606
EPS:
-4.84
순현금흐름:
$-13.49M
1주 성능:
+19.14%
1개월 성능:
-7.00%
6개월 성능:
-50.46%
1년 성능:
-73.28%
1일 변동 폭
$0.7746
$0.8254
1주일 범위
$0.6565
$0.8548
52주 변동 폭
$0.55
$3.76
Predictive Oncology Inc Stock (POAI) Company Profile
명칭
Predictive Oncology Inc
전화
412-432-1500
주소
91 43RD STREET, PITTSBURGH, MN
POAI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
POAI
Predictive Oncology Inc
|
0.7775 | 5.33M | 1.78M | -13.98M | -13.49M | -4.84 |
|
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
|
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
|
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
|
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
|
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-19 | 개시 | H.C. Wainwright | Buy |
Predictive Oncology Inc 주식(POAI)의 최신 뉴스
Predictive Oncology faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com South Africa
Predictive Oncology faces Nasdaq delisting over equity shortfall - Investing.com India
Predictive Oncology Receives Notice of Non-Compliance from Nasdaq - Defense World
Predictive Oncology Inc. Issues Press Release Detailing Financial Results for Q3 2024Predictive Oncology Inc., a leading biopharmaceutical company, released a pivotal press release detailing its financial results for the quarter ending September 30 - Defense World
This SolarEdge Technologies Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews
Predictive Oncology downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
Predictive Oncology Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Predictive Oncology Inc. Reports Q3 2024 Earnings - TipRanks
U.S. STOCKS BankUnited, Natera, Adaptimmune - XM
Artificial Intelligence in Drug Discovery Market Expecting Huge Demand in Upcoming Years - openPR
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update - The Manila Times
Predictive Oncology Reports Q3 Loss, Launches Strategic Review Amid 49% Revenue Drop | POAI Stock News - StockTitan
Predictive Oncology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
International Conference on the Crystallization of Biological Macromolecules - Arizona State University (ASU)
American Well Corporation (AMWL) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets™ - PR Newswire UK
Some Major Key Players In The Genomic Cancer Panel and Profiling Market: - InsightAce Analytic
AngioDynamics (ANGO) Stock Dips Amidst Financial Performance Rev - GuruFocus.com
, a machine learning-based RNA oncology test predicting immunotherapy response - Business Wire
HC Wainwright & Co. Initiates Coverage of Predictive Oncology (POAI) with Buy Recommendation - MSN
Artificial Intelligence in Genomics Market is Estimated to Reach $5.5 Billion By 2032 - 대구포스트
POAI stock touches 52-week low at $0.64 amid market challenges By Investing.com - Investing.com South Africa
Predictive Oncology Inc (POAI) Q2 2024 Earnings Call Highlights: Strategic Advances Amidst ... - Yahoo Finance
POAI stock touches 52-week low at $0.64 amid market challenges - Investing.com
Certis files patent for AI platform to ID predictive cancer biomarkers - BioWorld Online
HBIO Stock Drops Amidst Market Fluctuations - GuruFocus.com
POAI stock touches 52-week low at $0.74 amid market challenges By Investing.com - Investing.com South Africa
POAI stock touches 52-week low at $0.74 amid market challenges - Investing.com India
BioAI Announces Strategic Partnership with Arbele Bio to advance Predictive AI-Models in Oncology Clinical Trials - PR Newswire
11 Best AI Penny Stocks Under $10 in 2024 - CoinCodex
Predictive Oncology (NASDAQ:POAI) Shares Pass Below Two Hundred Day Moving Average of $1.42 - Defense World
Payoneer Global (NASDAQ:PAYO) Reaches New 52-Week High at $7.67 - MarketBeat
Strong Market Opportunities For OneStream Amid Rising Demand for AI-Driven Financial Solutions, Analyst Says - Yahoo Finance UK
TD Cowen analysts reiterates a Buy rating for PureCycle Technologies Inc (PCT) - Knox Daily
Prepare Yourself for Liftoff: Pyxis Oncology Inc (PYXS) - SETE News
Paylocity price target raised to $186 from $171 at TD Cowen - TipRanks
Paycor HCM, Inc. (PYCR): Short Seller Sentiment is Bearish on This AI Stock Under $50 - Yahoo Finance UK
Global Artificial Intelligence in Genomics Market Expected to Reach $ 5.5 Billion by 2032, Growing at 43.2% CAGR - 대구포스트
(PTGX) Trading Signals - Stock Traders Daily
Predictive Oncology faces NASDAQ delisting over share price - Investing.com India
Predictive Oncology faces NASDAQ delisting over share price By Investing.com - Investing.com Canada
Payoneer Global (NASDAQ:PAYO) Reaches New 52-Week High at $7.64 - Defense World
Paycor HCM Inc (PYCR) can make a big difference with a little luck - SETE News
(COHN) Technical Pivots with Risk Controls - Stock Traders Daily
Piper Sandler maintains Overweight rating on Opko Health shares on strong prospects - Investing.com Canada
PureCycle Technologies Inc (PCT) rating reiterates by TD Cowen - Knox Daily
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 - Tech Funding News
Cancer Profiling Market Growth Analysis, Industry Forecast To 2033 - WhaTech
Global Artificial Intelligence in Genomics Market Size, Share, Segmentation, Price Trends, Regional Analysis and Forecast 2024-2032 - 대구포스트
AI in Genomics Global Market Innovations Investigated by Technological Innovations and Market Growth - WhaTech
Predictive Oncology Inc (POAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
자본화:
|
볼륨(24시간):